Logo image of LCA

LANDCADIA HOLDINGS IV INC-A (LCA) Stock Fundamental Analysis

NASDAQ:LCA - Nasdaq - US51477A1043 - Common Stock - Currency: USD

10.54  -0.01 (-0.09%)

After market: 10.55 +0.01 (+0.09%)

Fundamental Rating

1

Taking everything into account, LCA scores 1 out of 10 in our fundamental rating. LCA was compared to 0 industry peers in the Unkown industry. LCA may be in some trouble as it scores bad on both profitability and health. LCA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

LCA had positive earnings in the past year.
In the past year LCA has reported a negative cash flow from operations.
LCA Yearly Net Income VS EBIT VS OCF VS FCFLCA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 5M 10M 15M 20M

1.2 Ratios

Industry RankSector Rank
ROA 55.67%
ROE 96.91%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LCA Yearly ROA, ROE, ROICLCA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 50 100 150 200

1.3 Margins

LCA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LCA Yearly Profit, Operating, Gross MarginsLCA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

2

2. Health

2.1 Basic Checks

LCA has less shares outstanding than it did 1 year ago.
The debt/assets ratio for LCA is higher compared to a year ago.
LCA Yearly Shares OutstandingLCA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 20M 40M 60M
LCA Yearly Total Debt VS Total AssetsLCA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

LCA has an Altman-Z score of 13.28. This indicates that LCA is financially healthy and has little risk of bankruptcy at the moment.
LCA has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 13.28
ROIC/WACCN/A
WACCN/A
LCA Yearly LT Debt VS Equity VS FCFLCA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 0 100M 200M 300M 400M

2.3 Liquidity

Industry RankSector Rank
Current Ratio 0
Quick Ratio 0
LCA Yearly Current Assets VS Current LiabilitesLCA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for LCA have decreased strongly by -81.82% in the last year.
EPS 1Y (TTM)-81.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 263.50, which means the current valuation is very expensive for LCA.
The average S&P500 Price/Earnings ratio is at 24.21. LCA is valued rather expensively when compared to this.
Industry RankSector Rank
PE 263.5
Fwd PE N/A
LCA Price Earnings VS Forward Price EarningsLCA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LCA Per share dataLCA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

LCA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LANDCADIA HOLDINGS IV INC-A

NASDAQ:LCA (2/27/2024, 8:00:03 PM)

After market: 10.55 +0.01 (+0.09%)

10.54

-0.01 (-0.09%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-29 2022-11-29/amc
Earnings (Next)N/A N/A
Inst Owners0.76%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap142.92M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 263.5
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 17.64
P/tB 17.64
EV/EBITDA N/A
EPS(TTM)0.04
EY0.38%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0
BVpS0.6
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 55.67%
ROE 96.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0
Quick Ratio 0
Altman-Z 13.28
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-81.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y67.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y74.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y74.06%
OCF growth 3YN/A
OCF growth 5YN/A